-
Sodium Orthovanadate: Precision Phosphorylation State Contro
2026-04-30
Sodium Orthovanadate (Na3VO4) is the gold-standard for reversible, high-fidelity preservation of protein phosphorylation states in cell signaling and kinase workflows. APExBIO's ultra-pure reagent supports advanced applications in metabolic and cancer research, enabling reproducible, high-sensitivity results even in complex experimental designs.
-
PLGA Nano-Adjuvant Enhances Mucosal and Systemic Immunity in
2026-04-30
This study introduces a novel PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly augments both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. The findings demonstrate improved intestinal targeting, sustained antigen release, and robust IgA production, offering practical advances for next-generation vaccine strategies.
-
Sulfo-Cy7 NHS Ester: Protocols and QC for Protein Labeling
2026-04-29
Cy7 NHS ester is used to label amino groups on proteins and peptides with near-infrared fluorescence, enabling sensitive in vivo and in vitro imaging. This reagent is ideal where water solubility and minimized quenching are critical, such as labeling delicate proteins or live-cell bioimaging. It is not suitable for applications requiring long-term dye solution stability or environments with high light exposure.
-
Ionizing Radiation Alters Neuronal Differentiation via PI3K-
2026-04-29
This study reveals that ionizing radiation (IR) triggers altered neuronal differentiation in C17.2 mouse neural stem-like cells through the PI3K-STAT3-mGluR1 pathway. Its mechanistic insights refine our understanding of radiation-induced neural effects, with implications for neurogenesis, radiotherapy outcomes, and methylation cycle research.
-
Ferritin Hybrid Vaccine Platform: M2e and SARS-CoV-2 Epitope
2026-04-28
This study presents a ferritin-based hybrid protein particle vaccine co-displaying influenza A M2e and SARS-CoV-2 spike protein epitopes, produced via E. coli expression. The hybrid particle demonstrated superior immunogenicity and functional antibody responses, highlighting the potential of ferritin scaffolds for efficient combination vaccine development.
-
Glycogen Colorimetric Assay Kit II: Robust Glycogen Quantifi
2026-04-28
The Glycogen Colorimetric Assay Kit II enables rapid, high-throughput quantification of tissue glycogen with colorimetric detection. Its enzymatic workflow offers sensitivity and resistance to interference, positioning it as a reliable tool for metabolic research and glycogen storage disease studies.
-
Ultrasound-Triggered Piezo-Nanoplatforms for Non-Invasive Ep
2026-04-27
This article examines a recent study introducing biomimetic piezoelectric nanoplatforms capable of non-invasive, ultrasound-triggered neuromodulation for epilepsy treatment. By integrating localized electrical stimulation and sustained drug delivery, the approach offers a promising alternative to conventional implant-based therapies, with implications for enhanced safety and efficacy.
-
Cholecystokinin Octapeptide Ammonium: Mechanisms and Transla
2026-04-27
Explore the multifaceted mechanisms of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) and its translational value in neurobiology, addiction, and immune modulation. This article uniquely interprets anxiety and opioid interactions for advanced assay design.
-
Jiawei Weijin Decoction Targets SPP1 to Inhibit NSCLC Metast
2026-04-26
Xu et al. (2025) identify Jiawei Weijin Decoction (JWWJD) and its active compound curcumol as direct inhibitors of SPP1, reducing metastasis in non-small cell lung cancer (NSCLC) models. Their study integrates network pharmacology, transcriptomics, and experimental validation, providing a mechanistic foundation for alternative NSCLC therapies.
-
Gly-Gly-Phe-Gly (GGFG): Enabling Flexible Linker Design in A
2026-04-25
Explore the scientific basis and practical applications of the GGFG peptide as a flexible linker in antibody-drug conjugate development and bioconjugation chemistry. This in-depth review highlights unique mechanistic insights and practical protocol guidance for researchers using Gly-Gly-Phe-Gly.
-
Temporal Transcriptomics Guides Host-Targeted Anti-EBOV Stra
2026-04-24
This study applies time-resolved transcriptomics and systems biology to dissect host responses during Ebola virus infection, revealing condition-specific gene modules amenable to therapeutic targeting. The work prioritizes host factors and identifies Sorafenib as an effective host-directed antiviral candidate for EBOV, offering a new framework for rational drug repurposing in emerging viral threats.
-
XPO1 Inhibition Boosts Platinum Sensitivity in GCB-DLBCL Cel
2026-04-24
This study demonstrates that pharmacological inhibition of XPO1, notably via Selinexor, synergistically enhances the efficacy of platinum-based chemotherapies in germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) models. The findings provide preclinical rationale for combining XPO1 inhibitors with platinum agents to overcome drug resistance in difficult-to-treat lymphoma subtypes.
-
3X (DYKDDDDK) Peptide: Redefining Translational Protein Scie
2026-04-23
This thought-leadership article explores the mechanistic foundation and strategic advantages of the 3X (DYKDDDDK) Peptide for translational protein research. By integrating recent mechanistic discoveries in host-pathogen biology, experimental validation, and advanced affinity workflows, the article provides translational researchers with actionable insights and a visionary outlook on leveraging this trimeric epitope tag for next-generation protein detection, purification, and structural studies. The discussion goes beyond routine product literature, drawing interdisciplinary connections and referencing the latest scientific findings.
-
Cy5 Maleimide (Non-sulfonated): Technical Guide for Protein
2026-04-23
Cy5 maleimide (non-sulfonated) enables site-specific fluorescent labeling of proteins and peptides via cysteine thiols, offering precise probe generation for imaging and assay development. It should be selected when high extinction coefficient, red-shifted emission, and selective cysteine targeting are required, but is not suitable for labeling biomolecules lacking accessible thiol groups or workflows incompatible with organic solvents.
-
Hierarchical ROS-Responsive Hydrogel Repairs Mitochondria in
2026-04-22
This study presents a hierarchically targeted, ROS-responsive nanoparticle-hydrogel platform for treating diabetic periodontitis by repairing mitochondrial dysfunction in M1 macrophages. The approach effectively interrupts the ROS-driven inflammatory loop and promotes alveolar bone regeneration, representing a significant translational advance for chronic inflammatory disease therapy.